Multiple Sclerosis (MS) or Clinically Isolated Syndrome (CIS) [in line with the locally approved indications] research hub

A Phase IV, Multicenter, Open-Label Study Evaluating B-Cell Levels in Infants Potentially Exposed to Ocrelizumab During Pregnancy – The MINORE Study

This study looks at babies born to mothers who received Ocrevus for MS during pregnancy. It checks babies' immune cells and health to understand the effects of the treatment on them. It's an important step for helping doctors and parents make informed decisions.